Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eckstein

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Infusionstherapie Und Transfusionsmedizin|April 1, 1994
[18 months experience with a new single needle cytapheresis system (Fresenius AS 104 SN)]T Zeiler, J Zingsem, V Weisbach, et al.
Vox Sanguinis|November 25, 2003
First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donorsJ Ringwald, J Zingsem, R Zimmermann, et al.
Vox Sanguinis|January 1, 1994
A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusionT Zeiler, G Wittmann, J Zingsem, et al.
Transfusion|July 21, 1999
Antibodies to private and public HLA class I epitopes in platelet recipientsR Zimmermann, G Wittmann, J Zingsem, et al.
Transfusion|September 30, 1999
The influence of automated plateletpheresis on systemic levels of hematopoietic growth factorsV Weisbach, H Friedlein, A Glaser, et al.
Genes, Chromosomes & Cancer|August 26, 2000
Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneityR Barnetson, J Jass, R Tse, et al.
Transfusion|March 29, 2001
Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donorsJ Zingsem, R Zimmermann, V Weisbach, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Anti-M after transfusion as an indication of a genetic variant of the MN locus]H G Heuft, V Weisbach, T Zeiler, et al.
Blut|April 1, 1985
Recognition of a positive MLR within 4 hours using a carrier free electrophoresis systemR Eckstein, W Mempel, M U Heim, et al.
Vox Sanguinis|April 23, 2015
Correlation of the hypotonic shock response and extent of shape change with the new ThromboLUX ™L Kraemer, T Raczat, D R Weiss, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Infusionstherapie Und Transfusionsmedizin|April 1, 1994
[18 months experience with a new single needle cytapheresis system (Fresenius AS 104 SN)]T Zeiler, J Zingsem, V Weisbach, et al.
Vox Sanguinis|November 25, 2003
First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donorsJ Ringwald, J Zingsem, R Zimmermann, et al.
Vox Sanguinis|January 1, 1994
A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusionT Zeiler, G Wittmann, J Zingsem, et al.
Transfusion|July 21, 1999
Antibodies to private and public HLA class I epitopes in platelet recipientsR Zimmermann, G Wittmann, J Zingsem, et al.
Transfusion|September 30, 1999
The influence of automated plateletpheresis on systemic levels of hematopoietic growth factorsV Weisbach, H Friedlein, A Glaser, et al.
Genes, Chromosomes & Cancer|August 26, 2000
Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneityR Barnetson, J Jass, R Tse, et al.
Transfusion|March 29, 2001
Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donorsJ Zingsem, R Zimmermann, V Weisbach, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Anti-M after transfusion as an indication of a genetic variant of the MN locus]H G Heuft, V Weisbach, T Zeiler, et al.
Blut|April 1, 1985
Recognition of a positive MLR within 4 hours using a carrier free electrophoresis systemR Eckstein, W Mempel, M U Heim, et al.
Vox Sanguinis|April 23, 2015
Correlation of the hypotonic shock response and extent of shape change with the new ThromboLUX ™L Kraemer, T Raczat, D R Weiss, et al.
Pageof 17